Xylem Reports Third Quarter 2023 Results
- Revenue of $2.1 billion, up 50% on a reported basis, and 10% organically
- Earnings per share of $0.63, up 800%; adjusted earnings per share of $0.99, up 14%
- Raising full-year revenue guidance to approximately $7.3B, up 32% from 30%, with expected organic revenue growth of 11%, up from 9% to 10%
- Lifting full-year adjusted EPS guidance to $3.71 to $3.73, from $3.50 to $3.70
WASHINGTON–(BUSINESS WIRE)–#LetsSolveWater–Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today reported third-quarter results. The Company’s total revenue was $2.1 billion, with reported growth of 50 percent and organic growth of 10 percent, surpassing prior guidance, on strong commercial and operational execution and resilient demand. Orders were up 43 percent on a reported basis and up 3 percent organically, while backlog grew 5 percent organically to $5.2 billion, including $1.3 billion from Evoqua. Third-quarter earnings exceeded Xylem’s previous guidance.
“The team capitalized on resilient demand to deliver another quarter of robust growth and continued margin expansion, with each of our segments outperforming expectations,” said Patrick Decker, Xylem president and CEO. “In addition to healthy organic growth, we saw strong operational performance in both our legacy business and in our recent Evoqua acquisition. The combination of these two great enterprises is delivering a robust pipeline of new commercial opportunities, and integration cost synergies are well on track. The team’s performance and continuing underlying demand give us confidence in raising our full-year guidance.”
“We are in a unique position as water challenges continue to intensify – bringing a transformative platform of solutions to customers and communities around the world. I have full confidence in the team to keep building on the foundation we’ve built to deliver the full potential of our strategy, drive further durability in our business model, and continue to create distinctive value for all our stakeholders.”
Net income was $152 million, or $0.63 per share. Net income margin increased 640 basis points to 7.3 percent. These results are driven by lapping a prior-year one-time pension settlement and strong operational performance, partially offset by higher acquisition and integration costs related to the Evoqua transaction, higher purchase accounting intangible amortization, and higher restructuring and realignment costs. Adjusted net income was $240 million, or $0.99 per share, which excludes the impacts of special charges, purchase accounting intangible amortization, and restructuring and realignment costs.
Third-quarter adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) margin was 19.8 percent, reflecting a year-over-year increase of 150 basis points. Excluding Evoqua’s results, adjusted EBITDA margin was 18.9 percent, up 60 basis points over the prior year period. Strong price realization more than offset inflation and, coupled with productivity savings and higher volume, drove the margin expansion, exceeding the impact of strategic investments.
Outlook
Xylem now expects full-year 2023 revenue of approximately $7.3 billion, up approximately 32 percent on a reported basis and up approximately 11 percent on an organic basis. This represents an increase from the Company’s previous full-year guidance of 30 percent on a reported basis and 9 to 10 percent on an organic basis.
Full-year 2023 adjusted EBITDA margin is expected to be approximately 19 percent, lifted from the previous guide of approximately 18 percent. This results in adjusted earnings per share of $3.71 to $3.73, raised from the previous range of $3.50 to $3.70.
Further 2023 planning assumptions are included in Xylem’s third-quarter 2023 earnings materials posted at www.xylem.com/investors. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort.
Third Quarter Segment Results
Measurement & Control Solutions
Xylem’s Measurement & Control Solutions segment consists of its portfolio of businesses in smart metering, network technologies, advanced infrastructure analytics, and analytic instrumentation.
- Third-quarter 2023 revenue was $440 million, up 26 percent on a reported basis and 25 percent organically, versus the prior year period. Growth was led by backlog execution in smart metering and test and measurement.
- Third-quarter reported operating income for the segment was $27 million, compared to a $2 million loss in the same period last year. Adjusted operating income, which excludes $1 million of special charges, $6 million of restructuring and realignment costs, and $16 million of purchase accounting intangible amortization, was $50 million, a 72 percent increase versus the prior year period, which was recast to add back $17 million of non-cash purchase accounting amortization. The segment reported operating margin was 6.1 percent, up 670 basis points versus the prior year period. Adjusted operating margin of 11.4 percent increased 310 basis points over the prior year period. Adjusted EBITDA margin was 15.7 percent, up 190 basis points from the prior year period. Higher volume, strong price realization, and productivity savings exceeded the impact of inflation and strategic investments.
Water Infrastructure
Xylem’s Water Infrastructure segment, now including legacy-Evoqua’s Applied Product Technologies segment, consists of its portfolio of businesses serving clean water delivery, wastewater transport and treatment, and dewatering.
- Third-quarter 2023 revenue was $803 million, a 40 percent increase on a reported basis and 7 percent organically, compared with the prior year period. This strong growth was driven by price realization and robust utilities and industrial demand, particularly in the U.S., and resilience in Western Europe, partially offset by a decline in Emerging Markets.
- Third-quarter reported operating income for the segment was $128 million, a 23 percent increase versus the same period last year. Adjusted operating income, which excludes $6 million of special charges, $3 million of restructuring and realignment costs, and $15 million of purchase accounting intangible amortization, was $152 million. This represents a 41 percent increase versus the prior year period, which was recast to add back $1 million of non-cash purchase accounting amortization. Reported operating margin for the segment was 15.9 percent, down 220 basis points versus the prior year period, and adjusted operating margin was 18.9 percent, up 10 basis points versus the prior year period. Adjusted EBITDA margin was 21.2 percent, up 50 basis points versus the prior year. Excluding Evoqua, adjusted EBITDA margin was 21.5 percent, up 80 basis points on the prior year. Favorable price realization net of inflation, productivity initiatives and higher volume more than offset strategic investments.
Applied Water
Xylem’s Applied Water segment consists of its portfolio of businesses in industrial, commercial building, and residential applications.
- Third-quarter 2023 revenue was $465 million, a 2 percent increase on a reported basis and 1 percent organically, year-over-year. Growth was driven by strong price realization, backlog execution in U.S. building solutions, and resilient industrial demand in developed markets, partially offset by softness in Emerging Markets.
- Third-quarter reported operating income for the segment was $73 million, a 5 percent decrease versus the same period last year. Adjusted operating income, which excludes $6 million of restructuring and realignment costs, was $79 million, a 1 percent increase versus the same period last year. The segment reported operating margin was 15.7 percent, down 110 basis points versus the prior year period. Adjusted operating margin of 17.0 percent was flat to the prior year period. Adjusted EBITDA margin was 18.3 percent, up 20 basis points from the prior year. Adjusted margin expansion was driven by price realization net of inflation and productivity savings, more than offsetting volume declines and strategic investments.
Integrated Solutions & Services
Xylem’s Integrated Solutions & Services segment consists of its portfolio of businesses providing water treatment systems and solutions, with an extensive service branch network and fleet of mobile assets.
- Third-quarter 2023 revenue was $368 million.
- Third-quarter reported operating loss for the segment was $3 million. Adjusted operating income was $49 million, which excludes $9 million of special charges, $8 million of restructuring and realignment costs, and $35 million of purchase accounting intangible amortization. The segment reported operating margin was (0.8) percent. Adjusted operating margin was 13.3 percent. Adjusted EBITDA margin was 22.6 percent, reflecting strong margin performance driven by effective price-cost discipline and volume conversion.
Supplemental information on Xylem’s third-quarter 2023 earnings and reconciliations for certain non-GAAP items is posted at www.xylem.com/investors.
About Xylem
Xylem (XYL) is a leading global water technology company committed to solving the world’s critical water, wastewater, and water-related challenges through technology, innovation, and expertise. Our more than 22,000 diverse employees delivered combined pro forma revenue of $7.3 billion in 2022. We are creating a more sustainable world by enabling our customers to optimize water and resource management and helping communities in more than 150 countries become water-secure. Join us in the effort at www.xylem.com and Let’s Solve Water.
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “contemplate,” “predict,” “forecast,” “likely,” “believe,” “target,” “will,” “could,” “would,” “should,” “potential,” “may” and similar expressions or their negative, may, but are not necessary to, identify forward-looking statements. By their nature, forward-looking statements address uncertain matters and include any statements that: are not historical, such as statements about our strategy, financial plans, outlook, objectives, plans, intentions or goals (including those related to our social, environmental and other sustainability goals); or address possible or future results of operations or financial performance, including statements relating to orders, revenues, operating margins and earnings per share growth.
Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, many of which are beyond our control. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in or implied by our forward-looking statements include, among others, the following: the impact of overall industry and general economic conditions, including industrial, governmental, and public and private sector spending, inflation, interest rates and related monetary policy by governments in response to inflation, and the strength of the residential and commercial real estate markets, on economic activity and our operations; geopolitical events, including the wars between Russia and Ukraine and between Israel and Hamas, and regulatory, economic and other risks associated with our global sales and operations, including with respect to domestic content requirements applicable to projects with governmental funding; actual or potential epidemics, pandemics or global health crises; availability, shortage or delays in receiving electronic components (in particular, semiconductors), parts and raw materials from our supply chain; manufacturing and operating cost increases due to macroeconomic conditions, including inflation, energy supply, supply chain shortages, logistics challenges, tight labor markets, prevailing price changes, tariffs and other factors; demand for our products, disruption, competition or pricing pressures in the markets we serve; cybersecurity incidents or other disruptions of information technology systems on which we rely or involving our products; disruptions in operations at our facilities or that of third parties upon which we rely; failure to successfully execute large projects, including with respect to meeting performance guarantees and customers’ safety requirements; our ability to retain and attract senior management and other diverse and key talent, as well as competition for overall talent and labor; difficulty predicting our financial results; defects, security, warranty and liability claims, and recalls with respect to products; safe and compliant handling of wastewater and hazardous materials; availability, regulation or interference with radio spectrum used by certain of our products; uncertainty related to restructuring and realignment actions and related costs and savings; our ability to continue strategic investments for growth; our ability to successfully identify, execute and integrate acquisitions; volatility in served markets or impacts on our business and operations due to weather conditions, including the effects of climate change; fluctuations in foreign currency exchange rates; our ability to borrow or refinance our existing indebtedness, and uncertainty around the availability of liquidity sufficient to meet our needs; risk of future impairments to goodwill and other intangible assets; failure to comply with, or changes in, laws or regulations, including those pertaining to anti-corruption, data privacy and security, export and import, our products, competition, and the environment and climate change; changes in our effective tax rates or tax expenses; legal, governmental or regulatory claims, investigations or proceedings and associated contingent liabilities; risks related to the acquisition of Evoqua, including related to our ability to retain and hire key personnel, the realization of expected benefits and synergies, the need to incur additional or unexpected costs, charges or expenses associated with the integration of the combined companies, delays or challenges with the integration, potential adverse reactions or changes to relationships with customers, suppliers, distributors and other business partners, competitive responses to the acquisition, actual or potential litigation and associated costs and expenses, and impacts to our share price and dilution of shareholders’ ownership; and other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2022 (“2022 Annual Report”) and in subsequent filings we make with the Securities and Exchange Commission (“SEC”).
Forward-looking and other statements in this press release regarding our environmental and other sustainability plans and goals are not an indication that these statements are necessarily material to investors or are required to be disclosed in our filings with the SEC. In addition, historical, current, and forward-looking social, environmental and sustainability-related statements may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future. All forward-looking statements made herein are based on information currently available to us as of the date of this press release. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
|
XYLEM INC. AND SUBSIDIARIES |
|||||||||||
|
CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited) |
|||||||||||
|
(in millions, except per share data) |
|||||||||||
|
|
Three Months |
|
Nine Months |
||||||||
|
For the period ended September 30, |
2023 |
|
2022 |
|
2023 |
|
2022 |
||||
|
Revenue from products |
$ |
1,720 |
|
$ |
1,243 |
|
$ |
4,535 |
|
$ |
3,625 |
|
Revenue from services |
|
356 |
|
|
137 |
|
|
711 |
|
|
391 |
|
Revenue |
|
2,076 |
|
|
1,380 |
|
|
5,246 |
|
|
4,016 |
|
Cost of revenue from products |
|
1,043 |
|
|
740 |
|
|
2,730 |
|
|
2,160 |
|
Cost of revenue from services |
|
269 |
|
|
116 |
|
|
555 |
|
|
345 |
|
Cost of revenue |
|
1,312 |
|
|
856 |
|
|
3,285 |
|
|
2,505 |
|
Gross profit |
|
764 |
|
|
524 |
|
|
1,961 |
|
|
1,511 |
|
Selling, general and administrative expenses |
|
491 |
|
|
294 |
|
|
1,291 |
|
|
912 |
|
Research and development expenses |
|
61 |
|
|
47 |
|
|
172 |
|
|
152 |
|
Restructuring and asset impairment charges |
|
21 |
|
|
15 |
|
|
57 |
|
|
22 |
|
Operating income |
|
191 |
|
|
168 |
|
|
441 |
|
|
425 |
|
Interest expense |
|
14 |
|
|
12 |
|
|
35 |
|
|
37 |
|
U.K. pension settlement expense |
|
— |
|
|
140 |
|
|
— |
|
|
140 |
|
Other non-operating income, net |
|
8 |
|
|
1 |
|
|
19 |
|
|
2 |
|
Gain from sale of business |
|
— |
|
|
— |
|
|
— |
|
|
1 |
|
Income before taxes |
|
185 |
|
|
17 |
|
|
425 |
|
|
251 |
|
Income tax expense |
|
33 |
|
|
5 |
|
|
82 |
|
|
45 |
|
Net income |
$ |
152 |
|
$ |
12 |
|
$ |
343 |
|
$ |
206 |
|
Earnings per share: |
|
|
|
|
|
|
|
||||
|
Basic |
$ |
0.63 |
|
$ |
0.07 |
|
$ |
1.64 |
|
$ |
1.14 |
|
Diluted |
$ |
0.63 |
|
$ |
0.07 |
|
$ |
1.63 |
|
$ |
1.14 |
|
Weighted average number of shares: |
|
|
|
|
|
|
|
||||
|
Basic |
|
240.9 |
|
|
180.2 |
|
|
208.9 |
|
|
180.2 |
|
Diluted |
|
242.2 |
|
|
180.9 |
|
|
210.1 |
|
|
180.9 |
|
XYLEM INC. AND SUBSIDIARIES |
|||||||
|
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) |
|||||||
|
(in millions, except per share amounts) |
|||||||
|
|
September 30, 2023 |
|
December 31, 2022 |
||||
|
|
|
|
|
||||
|
ASSETS |
|
|
|
||||
|
Current assets: |
|
|
|
||||
|
Cash and cash equivalents |
$ |
705 |
|
|
$ |
944 |
|
|
Receivables, less allowances for discounts, returns and credit losses of $55 and $50 in 2023 and 2022, respectively |
|
1,653 |
|
|
|
1,096 |
|
|
Inventories |
|
1,080 |
|
|
|
799 |
|
|
Prepaid and other current assets |
|
213 |
|
|
|
173 |
|
|
Total current assets |
|
3,651 |
|
|
|
3,012 |
|
|
Property, plant and equipment, net |
|
1,132 |
|
|
|
630 |
|
|
Goodwill |
|
7,149 |
|
|
|
2,719 |
|
|
Other intangible assets, net |
|
3,039 |
|
|
|
930 |
|
|
Other non-current assets |
|
934 |
|
|
|
661 |
|
|
Total assets |
$ |
15,905 |
|
|
$ |
7,952 |
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
||||
|
Current liabilities: |
|
|
|
||||
|
Accounts payable |
$ |
943 |
|
|
$ |
723 |
|
|
Accrued and other current liabilities |
|
1,160 |
|
|
|
867 |
|
|
Short-term borrowings and current maturities of long-term debt |
|
17 |
|
|
|
— |
|
|
Total current liabilities |
|
2,120 |
|
|
|
1,590 |
|
|
Long-term debt |
|
2,253 |
|
|
|
1,880 |
|
|
Accrued post-retirement benefits |
|
281 |
|
|
|
286 |
|
|
Deferred income tax liabilities |
|
724 |
|
|
|
222 |
|
|
Other non-current accrued liabilities |
|
586 |
|
|
|
471 |
|
|
Total liabilities |
|
5,964 |
|
|
|
4,449 |
|
|
|
|
|
|
||||
|
Stockholders’ equity: |
|
|
|
||||
|
Common stock – par value $0.01 per share: |
|
|
|
||||
|
Authorized 750.0 shares, issued 256.7 shares and 196.0 shares in 2023 and 2022, respectively |
|
3 |
|
|
|
2 |
|
|
Capital in excess of par value |
|
8,529 |
|
|
|
2,134 |
|
|
Retained earnings |
|
2,416 |
|
|
|
2,292 |
|
|
Treasury stock – at cost 15.9 shares and 15.8 shares in 2023 and 2022, respectively |
|
(718 |
) |
|
|
(708 |
) |
|
Accumulated other comprehensive loss |
|
(300 |
) |
|
|
(226 |
) |
|
Total stockholders’ equity |
|
9,930 |
|
|
|
3,494 |
|
|
Non-controlling interests |
|
11 |
|
|
|
9 |
|
|
Total equity |
|
9,941 |
|
|
|
3,503 |
|
|
Total liabilities and stockholders’ equity |
$ |
15,905 |
|
|
$ |
7,952 |
|
|
XYLEM INC. AND SUBSIDIARIES |
|||||||
|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (in millions) |
|||||||
|
For the nine months ended September 30, |
2023 |
|
2022 |
||||
|
Operating Activities |
|
|
|
||||
|
Net income |
$ |
343 |
|
|
$ |
206 |
|
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
||||
|
Depreciation |
|
132 |
|
|
|
83 |
|
|
Amortization |
|
167 |
|
|
|
93 |
|
|
Share-based compensation |
|
45 |
|
|
|
28 |
|
|
Restructuring and asset impairment charges |
|
57 |
|
|
|
22 |
|
|
U.K. pension settlement expense |
|
— |
|
|
|
140 |
|
|
Gain from sale of business |
|
— |
|
|
|
(1 |
) |
|
Other, net |
|
(20 |
) |
|
|
(9 |
) |
|
Payments for restructuring |
|
(12 |
) |
|
|
(7 |
) |
|
Changes in assets and liabilities (net of acquisitions): |
|
|
|
||||
|
Changes in receivables |
|
(142 |
) |
|
|
(145 |
) |
|
Changes in inventories |
|
(41 |
) |
|
|
(214 |
) |
|
Changes in accounts payable |
|
15 |
|
|
|
47 |
|
|
Changes in accrued and deferred taxes |
|
(77 |
) |
|
|
(12 |
) |
|
Other, net |
|
(85 |
) |
|
|
3 |
|
|
Net Cash – Operating activities |
|
382 |
|
|
|
234 |
|
|
Investing Activities |
|
|
|
||||
|
Capital expenditures |
|
(177 |
) |
|
|
(148 |
) |
|
Acquisitions of businesses, net of cash acquired |
|
(476 |
) |
|
|
— |
|
|
Proceeds from sale of business |
|
103 |
|
|
|
1 |
|
|
Proceeds from the sale of property, plant and equipment |
|
2 |
|
|
|
3 |
|
|
Cash received from investments |
|
1 |
|
|
|
5 |
|
|
Cash paid for investments |
|
(1 |
) |
|
|
(9 |
) |
|
Cash paid for equity investments |
|
(58 |
) |
|
|
(2 |
) |
|
Cash received from interest rate swaps |
|
38 |
|
|
|
— |
|
|
Cash received from cross-currency swaps |
|
25 |
|
|
|
24 |
|
|
Other, net |
|
4 |
|
|
|
3 |
|
|
Net Cash – Investing activities |
|
(539 |
) |
|
|
(123 |
) |
|
Financing Activities |
|
|
|
||||
|
Short-term debt issued, net |
|
1 |
|
|
|
— |
|
|
Long-term debt issued, net |
|
275 |
|
|
|
— |
|
|
Long-term debt repaid |
|
(155 |
) |
|
|
— |
|
|
Repurchase of common stock |
|
(10 |
) |
|
|
(52 |
) |
|
Proceeds from exercise of employee stock options |
|
45 |
|
|
|
6 |
|
|
Dividends paid |
|
(219 |
) |
|
|
(163 |
) |
|
Other, net |
|
(8 |
) |
|
|
(1 |
) |
|
Net Cash – Financing activities |
|
(71 |
) |
|
|
(210 |
) |
|
Effect of exchange rate changes on cash |
|
(11 |
) |
|
|
(64 |
) |
|
Net change in cash and cash equivalents |
|
(239 |
) |
|
|
(163 |
) |
|
Cash and cash equivalents at beginning of year |
|
944 |
|
|
|
1,349 |
|
|
Cash and cash equivalents at end of period |
$ |
705 |
|
|
$ |
1,186 |
|
|
Supplemental disclosure of cash flow information: |
|
|
|
||||
|
Cash paid during the period for: |
|
|
|
||||
|
Interest |
$ |
43 |
|
|
$ |
67 |
|
|
Income taxes (net of refunds received) |
$ |
159 |
|
|
$ |
57 |
|
| Xylem Inc. Non-GAAP Measures |
| Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or “adjusted”) measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends, acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following items to represent the non-GAAP measures we consider to be key performance indicators, as well as the related reconciling items to the most directly comparable measure calculated and presented in accordance with GAAP. The non-GAAP measures may not be comparable to similarly titled measures reported by other companies. |
| “Organic revenue” and “Organic orders” defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales or discontinuance of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate. |
| “Constant currency” defined as financial results adjusted for foreign currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. dollar. |
| “EBITDA” defined as earnings before interest, taxes, depreciation and amortization expense. “Adjusted EBITDA” and “Adjusted Segment EBITDA” reflect the adjustments to EBITDA and segment EBITDA, respectively, to exclude share-based compensation charges, restructuring and realignment costs, gain or loss from sale of businesses and special charges. |
| “Adjusted EBITDA Margin” and “Adjusted Segment EBITDA Margin” defined as adjusted EBITDA and adjusted segment EBITDA divided by total revenue and segment revenue, respectively. |
| “Adjusted Operating Income”, “Adjusted Segment Operating Income”, “Adjusted Net Income” and “Adjusted EPS” defined as operating income, segment operating income, net income and earnings per share, adjusted to exclude restructuring and realignment costs, amortization of acquired intangible assets, gain or loss from sale of businesses, special charges and tax-related special items, as applicable. |
| “Adjusted Operating Margin” and “Adjusted Segment Operating Margin” defined as adjusted operating income and adjusted segment operating income divided by total revenue and segment revenue, respectively. |
| “Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flows, less capital expenditures, and “Free Cash Flow Conversion” defined as Free Cash Flows divided by net income, excluding the gain on sale of businesses and other non-recurring, significant non-cash impacts, such as non-cash impairment charges and significant deferred tax items. Our definitions of “free cash flow” and “free cash flow conversion” do not consider certain non-discretionary cash payments, such as debt. |
| “Adjusted Free Cash Flow” defined as free cash flow adjusted for significant cash items for which the corresponding income statement impact does not occur within the same fiscal year. |
| “Realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs. |
| “Special charges” defined as costs incurred by the Company, such as acquisition and integration related costs, non-cash impairment charges and both operating and non-operating adjustments for costs related to the UK pension plan buyout. |
| “Tax-related special items” defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, excess tax benefits/losses and other discrete tax adjustments. |
Contacts
Media
Houston Spencer +1 (914) 323-5723
Investors
Andrea van der Berg +1 (914) 260-8612
